Corticosteroid-induced dermal atrophy has been studied in the rat using daily application of ethanolic solutions to small areas of flank skin. After 12 days of treatment, the degree of atrophy was determined by comparing the weights of skin plugs (16 mm diameter) taken from the treated areas with contralaterally paired control areas. Doses can be adjusted so that systemic effects are minimized and only local effects are observed. Hydrocortisone, hydrocortisone butyrate, dexamethasone, betamethasone, desonide and triamcinolone acetonide all produce atrophy in the rat, and the degree of thinning is dose dependent. Potencies in the dermal atrophy assay compare directly with topical anti-inflammatory potencies in the rat, and the presence of fluorine in the steroid molecule is not a determining factor in the production of atrophy.
Corticosteroid-induced dermal atrophy has been studied in the rat using daily application of ethanolic solutions to small areas of flank skin. After 12 days of treatment, the degree of atrophy was determined by comparing the weights of skin plugs (16 mm diameter) taken from the treated areas with contralaterally paired control areas. Doses can be adjusted so that systemic effects are minimized and only local effects are observed. Hydrocortisone, hydrocortisone butyrate, dexamethasone, betamethasone, desonide and triamcinolone acetonide all produce atrophy in the rat, and the degree of thinning is dose dependent. Potencies in the dermal atrophy assay compare directly with topical anti-inflammatory potencies in the rat, and the presence of fluorine in the steroid molecule is not a determining factor in the production of atrophy.
Corticosteroid-induced dermal atrophy is well recognized as a potential consequence of prolonged topical use of potent corticosteroids. Although the original description of the phenomenon by Epstein et al [1] , appeared in 1963, experimental investigations in this area were not forthcoming until recently. Because the clinical atrophy effect was observed primarily with the more potent synthetic steroids. it became associated with the presence of fluorine in the molecule [2, 3] with the resulting implication that nonhalogenated corticosteroids would not cause atrophy [3] [4] [5] . However, Castor and Baker f6) had shown as early as 1950 that topical application of hydrocortisone to the skin of rats caused dermal thinning. Recent publications [5, [7] [8] [9] [10] [11] [12] [13] indicate the development of an experimental approach to the problem and the need for methodology appropriate to quantification of dermal atrophy effects.
We have examined the dermal atrophy potential of a series of halogenated and nonhalogenated corticosteroids in the rat. In this paper we describe the advantage and limitations of a model system in which atrophogenicity can be quantified on the basis of dose-response relationships, and the relative potencies of atrophogenic steroids can be evaluated.
MATERlALS AND METHODS
Male albino rats <Sprague-Dawley derived, Simonsen Labs) weighing 170 ±: 10 gm were lightly anesthetized with ether, shaved on the back and flanks with electric clippers, and for each rat, 6 bilaterally paired sites, 3 on each flank, were marked by intradermal injection of India ink. The areas on the left flank served as solvent-treated controls and received 10 ~-t-1 of ethanol daily; the paired areas on the right flank Manuscript received Feb 4, 1977 On day 12. twenty-four hours after the final applications, the animals were killed and the full-thkkness skin from the shaved area was removed. The skin was spread uniformly without stretching over a thin layer of water on a Teflon board. and 16-mm diameter circles centered over each tatoo mark were punched out. Each plug was freed from adherent fat and muscle by scraping with a dull scalpel. The plugs were blotted on lightly moistened filter paper and weighed to the nearest miligram. In some cases further treatment consisted of -(] ) drying t o constant weight at 1 oo·c a nd reweighing, (21 processing appropriate t o various histological procedures, or (3) preparing for the chemical analyses described below.
For chemical analyses, the plugs were dried at 10o•c for 16 hours and broken into roughly equal pieces, each of which was weighed. Hexosamine was assayed by hydrolyzing the sample in 5 ml of 4 N HCI at 1oo•c for 17 hours in tightly capped tubes. After the tubes had cooled, 20 mg of powdered charcoal wer e added to each, and after 10 minutes the mixtures were filtered. Duplicate 1-ml aliquots were then assayed for hexosamine according to the method of Boas f 14]. For hydroxyproline analysis, the samples were hydrolyzed in 3 ml of 6 N H Cl at 125•c for 16-18 hours. evaporated to dryness and redissolved in 3 ml water. The samples were treated with charcoal (20 mgJ. filtered, and aliquots of the filtrate were diluted for analysis of hydroxyproline content according to the method of Woessner prednisolone ( 11{3,17 a ,21-trihydroxypregna-1 ,4-diene-3,20-dione) a nd desonide C llf3,16a,l7c.t,21-tetrahydroxypregna-1,4-diene-3,2Q..dione cyclic 16,17-acetal with acetone) were synthesized at Syntex Research .
RESULTS
Skin thickness in the rat is markedly dependent on the phase of the hair growth cycle 16, 16] , and corticosteroids are known to inhibit the initiation but not the continuation of new hair growth 117]. Therefore, consideration was given to selecting rats in which one growth wave was well-establish ed and the next would not begin within the experimental period. Rats of a pproximately 170 gm were selected; the maximum in plug weights at approximately 41 days tFig 1) represents t.he onset of catagen of the second growth wave, when mitotic activity in the hair bulb ceases. Over the next several days, the hair continues to erupt as the base of the hai r shaft moves upwards in the dermis to assume its final resting position just below the base of the sebaceous gland. Reshaving on one or two occasions is necessary only during the first week of treatment. The catagen phase of hair growth , wh ich begins at 18 days for the first growth wave a nd at 41 days for the secon~. is associated with a slight thinning of the derffils as reflected by the decrease in plug weights. Animals of this size have a consistently large and reproducible weight gain in spite of daily handli ng, and any dimunition of the expected gain serves a. a sensitive indicator of systemic effects resulting from percutaneous absorption.
In tht• initial experiments we decided not LOuse restraints, occlusion or protective dressings because of t.he extra work involved and the stressful effects on the animals. Instead. each ani mal served as its own control (each treated plug compared with its contralateral control withi~ the same animal) so that, even though the anunals migh t ingest some of the solvent deposited materia] during grooming. a s trictl y local effect would still be a pparent. Ingestion of the solvent depos-
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Ftc 1. Body weight and skin plug weight in male albino rats (Simonsen, Sprague-Dawley den ved l. For each point on th e plug weight curve. groups of 6 animals were used and three 16-mm plugs were obtained from each flank as described_ in "Mater~al~ and
Methods." The vertical arrows ind1cate the hm1ts of the treatment period.
STEROID ATROPHY l N THE RAT 459 ited material is judged not to be a problem since only microgram quantities of steroid are applied, and at the end of the treatment period, particularly with the higher concentrations of the more potent steroids, the three treated areas appear grossly as very circumscribed (1. 5-2.0 em diameter) white areas obviously thinner than the surrounding normal skin .
The data for some representative corticosteroids are shown in Table I . Substantial differences in weight exist for the three plugs taken from the same Dank; however. in control animals, there is little difference in weight between plugs taken from the same areas on opposite flanks. Representative weights of plugs for a control animal are: 270, 275; 278, 271; 224, 221 mg ()eft and right flank; sh oulder , midflank and pelvic region , respectively). Since this normal variation would mask small dermal atrophy effects if the three plugs from each side were averaged before comparing treated with control plugs. each treated plug is compared with its contralateral control and the decrease in weight for that plug is expressed as a percent of the control plug weight_ (last colum~. Table I ). The repeat experiments with hydrocortisone and triamcinolone acetonide s how that the percent differences are reproducible. even though the absolute weights of control and treated plugs may show substantial variation.
. Body weight gains are included here as a momtor of absorption and systemic effects. Betamethasone and dexamethasone show s uch systemic effects at the highest dose levels. whereas hydrocortisone does not. Triamci nolone acetonide a t the 0.03'k ( 9 p.g per day) level also showed systemic effects tTable IV). One consequence of this systemic effect is a general thinning of the skin over the whole body. so that the control plug weights a re lower than expected. Nevertheless. a local effect is still discernible.
Plots of percent decrease in treated plug weight versus the log percent concentration of th e test compounds \Fig 2l are linear and parallel for most compounds tested. F or each compound , the best straight line was fitted to the data by the method of least squares, and potencies relative to hydrocortisone were calculated using the exact method of Finney 118).
It was of interest to compare the derma l atrophy potencies of these compounds \\<ith some measure of topical anti-infla mmatory activity in the sam_e species. and data obtained from the croto~-01l induced infl ammation in the rat ear as descnbed by Tonelli . Thibault, and Ringer 119] ap~eared suitable. In this latter assay, a l lk solutiOn of croton oil in eth er-water-pyridine (15: 1:4) alone or with the appropriate concentration of steroid, is applied to one ear of 21-day-old rats. After 6 hours the treated ears are removed. uniform plugs' are punched out, and the plugs. weig~ed~
Plugs from inflamed ears show substa~~1al we1ght increases relative to controls, and anti-Inflammatory corticosteroids inhibit this weight increase in a dose-responsP manner. In spite of the obvious differences between the two assays, particularly with respect to time. application site and solvents, the correspondence is remarkably good. A pJot of the relative potencies <hydrocortisone = 1 l in the two assays is sh own in Figure 3 . The correlation coefficient calculated from the data in Table I1 is 0.99 (with a slope of 1.06 and intercept of 6.26). indicating a very high degree of correlation between activities in the two assays for these compounds.
Skin plugs from rats treated with 0.01 %: triamcinolone acetonide were subjected to further analysis in order to confirm the histological finding that protein loss had indeed occurred. On drying to constant weight, the treated plugs still showed a significant weight loss (Table ill) which was reflected in decreased hexosamine and hydroxyproline contents of the plugs. The treated plugs had a slightly lower water content (65%) than the control plugs (69%), but this was to be expected since collagen (hydroxyproline) and mucopolysaccharide (h exosamine) are highly hydrated relative to keratin and other proteins.
In order to investigate the reversibility of the atrophy process, groups of animals were treated with 0.03~ triamcinolone acetonide on days 1-5 and 8-11 as usual. One group was sacrificed on day 12, and the remaining groups without further treatment were sacrificed at weekly intervals thereafter. From the results presented in Table  IV it can be seen that the corticosteroid-treated skin returns Lo normal weight by three weeks after cessation of treatment. The abrupt thickening of the atrophied areas between days 26 and 33 is not easily explained, but is probably related to
Frc 3. Correlation between anti-inflammatory potency and dermal atrophy for \'arious steroids in the rat. In each assay the potencies were determined relative to hydrocortisone= l. (Fig 1) . DISCUSSION As originally shown by Castor and Baker [6] , it is possible to induce atrophic changes in dermis of rats by topical application of adrenocortical steroids. In addition to the obvious histological changes. our studies show that the atrophy is associated with a decrease in both collagen and mucopolysaccharide, a nd is not simply a vasoconstrictive-like effect leading to decreases in fluid content of the tissues. Furthermore, since each a nimal serves as its own control, it is clear that the atrophy is a strictly local effect and is re- " Anti-inflammatory activities were det ermined using the croton oil-induced ear edema method of Tonelli, Thibault, and Ringer [19) . Data on file at Syntex Research.
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• Graphical estimate only. In both these studies it is impossible to discriminate between truly local efJects and general systemic impairment of metabolism. With respect t o the effect of halogen substitution in the steroid molecule. our studies show that it is not the determining factor in dermal atrophy. Hydrocortisone. hydroc01-tisone butyrate. and desonide all produce dermal atrophy to a degree entirely consistent with their antiinflammatory activities. In a study involving both mouse and human (10] , hydrocortisone and its butyrate produced atrophy in both species, and in the human hydrocortisone butyrate produced the greatest degree of skin thinning of all compounds tested.
For the limited number of compounds tested. dermal atrophy potency correlates very well with anti-inflammatory activity. but it is hoped that further testing will lead to the identification of compounds which show desirable separations of activity in the two assays. Since ethical considerations preclude extensive screening for derma l atrophy in humans, an animal model must be used, and this rat assay serves well since it gives a rapid and sensitive response which can be quantitated gravimetrically. Furthermore, anti-inflammatory and dermal atrophy assays ar e carried out in the same species. so that separations of activity are readily detectable.
One note of caution -it must be remembered that anti-inflammatory activities of steroids differ in the rat and in the human 1201. and it is to be expected that relative dermal atrophy potencies wouJd also change between species. In addition. these studies were carried out ..... ;th solvent deposited steroids. whereas in practice the steroids are formulated. some optimally and some poorly. Therefore, it would be dangerous to extrapolate relative rat dermal atrophy potency directly to the human without taking into account any differences in anti-inflammatory potency.
The rat ear anti-inflammatory data were generated in th e Bioassay Department. Syntex Institute of Biological Sciences, under the direction of Mr. Wendell Rooks to whom we are indebted.
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